Production issues with Pfizer’s injectable version of naloxone, a lifesaving overdose reversal drug, has caused a shortage of the drug, affecting healthcare providers across the country, The Boston ...

Since it began more than two decades ago, the opioid epidemic has taken an enormous toll on people’s lives. In 2022 alone, the U.S. Centers for Disease Control estimates that approximately 80,000 ...

Naloxone, sold under the brand name Narcan, offers an over-the-counter medication that rapidly reverses the effects of opioid overdoses. Despite efforts to make it more widely available, high prices ...

Figure illustrates the proportion of Medicaid managed care plans (MCP) in state covering at least one generic injectable or generic or brand intranasal naloxone formulation without any restrictions.

In the event of an opioid overdose, naloxone can restore normal breath to a person whose breathing has slowed or stopped — potentially saving a life, according to the National Institute on Drug Abuse.

The U.S. Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold ...

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...

Add Yahoo as a preferred source to see more of our stories on Google. B.C. to expand access to nasal naloxone to prevent overdose deaths The B.C. government is allocating $18 million in new money for ...

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose reversal drug naloxone, although certain restrictions and quantity limits may ...